Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : View from the Center and Left -- Ignore unavailable to you. Want to Upgrade?

To: MulhollandDrive who wrote (13652)	3/1/2006 5:56:51 PM
From: epicure	Respond to of 541478

The schools can do little to make parents better nutritional guides, and I have to say that parents are really doing a poor job. A survey in one of my classes turned up only one girl who ate dinner with her parents every night, and she was also the only one whose mother made her a healthy lunch (interestingly she also had the top grade in my class). All schools can do is ban junk food, and serve healthy lunches. IMO all foods offered in schools should conform to the best nutritional guidelines. If kids don't eat it, then they don't eat it- but at least the schools will be fulfilling their function as a model for what is exemplary. I doubt the ban in schools is making kids binge any more than they already do. If you ever get any hard data on it post it here- but I doubt you will find that data.

To: MulhollandDrive who wrote (13652)	3/1/2006 8:11:22 PM
From: mph	Respond to of 541478

Speaking of warnings, labelling etc: Compulsive Gamblers Blame Dopamine Drug For Their Addictions MINNEAPOLIS (CN) – Seven plaintiffs have sued four major pharmaceutical companies in Federal Court, claiming the drug Mirapex, prescribed for restless legs syndrome, gave them a pathological addiction to gambling. The patients claim in separate lawsuits that Mirapex, a dopamine agonist, works on dopamine receptors in the mesolimbic pathway, the brain area associated with pleasure, reward-seeking behavior and reinforcement. The FDA approved Mirapex for Parkinson’s disease in 1997 and defendants immediately began pushing it for restless legs syndrome, without warning doctors it could cause compulsive behaviors such as gambling addiction, the complaint states. The defendants changed the product literature in March 2005, stating on pages 17 and 21 of the “adverse reactions” section that Mirapex could cause “compulsive behaviors including sexual and pathological gambling,” but did not put this warning on the label, the suit states. Defendants are Boehringer Ingelheim Pharmaceuticals, Pfizer, Pharmacia Corp., and Pharmacia & Upjohn. See story.